Results 181 to 190 of about 21,135 (199)
Some of the next articles are maybe not open access.
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Lancet, The, 2017 Paul E Sax, Anton L Pozniak, Andrea Antinori +2 moreexaly Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Lancet, The, 2017 Adriano Lazzarin, Chloe Orkin, Daniel Podzamczer +2 moreexaly Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
Lancet, The, 2012 Paul E Sax, Anthony M Millsexaly 
